These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2443873)

  • 21. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
    J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
    Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
    Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer.
    Claudio F; Cacace F; Comella G; Coucourde F; Claudio L; Bevilacqua AM; Toma S
    Cancer; 1990 Apr; 65(7):1465-71. PubMed ID: 1690075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
    Mack F; Schäfer N; Kebir S; Stuplich M; Schaub C; Niessen M; Scheffler B; Herrlinger U; Glas M
    Oncology; 2014; 86(5-6):369-72. PubMed ID: 24942787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraarterial cis-platinum chemotherapy for patients with primary and metastatic brain tumors.
    Lehane DE; Bryan RN; Horowitz B; DeSantos L; Ehni G; Zubler MA; Moiel R; Rudolph L; Aldama-Leubbert A; Mahoney D
    Cancer Drug Deliv; 1983; 1(1):69-77. PubMed ID: 6544119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine].
    Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM
    Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy of malignant gliomas: studies of the BTCG.
    Shapiro WR
    Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas.
    Vance RB; Pittisapu J; Kapp JP
    J Neurooncol; 1986; 4(2):151-4. PubMed ID: 3783209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
    Jeremić B; Grujicić D; Jevremović S; Mijatović Lj
    Srp Arh Celok Lek; 1991; 119(9-10):256-8. PubMed ID: 1806994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
    Watne K; Hager B
    J Neurooncol; 1987; 5(1):47-50. PubMed ID: 3598620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of intracarotid PCNU.
    Stewart DJ; Grahovac Z; Russel NA; Hugenholtz H; Gupta S; Benoit BC; Richard MT; Maroun JA; Hopkins HS; Locke L
    J Neurooncol; 1987; 5(3):245-50. PubMed ID: 3681387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.
    Shapiro WR; Green SB; Burger PC; Mahaley MS; Selker RG; VanGilder JC; Robertson JT; Ransohoff J; Mealey J; Strike TA
    J Neurosurg; 1989 Jul; 71(1):1-9. PubMed ID: 2661738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
    Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
    J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Burch PA; Schaefer PL; Dinapoli RP; Novotny PJ; Scheithauer BW; Rowland KM; Vukov AM; Mailliard JA; Morton RF
    J Clin Oncol; 1998 Sep; 16(9):2953-8. PubMed ID: 9738563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma.
    Rogers LR; Purvis JB; Lederman RJ; Rosenbloom SA; Tomsak RL; Estes ML; Magdinec M; Medendorp SV; Boyett JM
    Cancer; 1991 Jul; 68(1):15-21. PubMed ID: 2049736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
    Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
    Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
    Bessell EM; Graus F; Punt JA; Firth JL; Hope DT; Moloney AJ; Lopez-Guillermo A; Villa S
    J Clin Oncol; 1996 Mar; 14(3):945-54. PubMed ID: 8622044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
    Kuroiwa T; Naito S; Hasuo K; Kishikawa T; Masuda K; Kumazawa J
    Cancer Chemother Pharmacol; 1995; 35(5):357-63. PubMed ID: 7850915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
    Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
    Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.